Business Wire

Sensile Medical Enters into an Agreement with scPharmaceuticals for Advanced Subcutaneous Drug Delivery System

The SenseCore technology offers opportunities for improved therapy outcomes and healthcare cost reduction HAEGENDORF, Switzerland--(BUSINESS WIRE)--Sensile Medical AG has entered into a strategic ...
Business Wire

First US FDA Submission of Wearable Drug-Device Combination Product Based on Sensile Medical's SensePatch Drug Delivery Technology

OLTEN, Switzerland--(BUSINESS WIRE)--Sensile Medical, a global leader in Large Volume Injector devices based on the cost-efficient and highly accurate SenseCore micro pump technology platform, today ...
technologynetworks

Sensile Medical Enters into an Agreement with scPharmaceuticals

Sensile Medical AG has entered into a strategic partnership and supply agreement with scPharmaceuticals LLC to develop and manufacture an automated patch pump that delivers furosemide subcutaneously.
FiercePharma

scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates

Boston, MA – scPharmaceuticals LLC today announced that it has entered into a strategic partnership and product development agreement with Sensile Medical Holding AG of Zug, Switzerland to develop an ...
FiercePharma

Sensile Medical Enters into an Agreement with scPharmaceuticals for Advanced Subcutaneous Drug Delivery System

Sensile Medical AG has entered into a strategic partnership and supply agreement with scPharmaceuticals LLC to develop and manufacture an automated patch pump that delivers furosemide subcutaneously.